ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

This study has been completed.

Study NCT00025116 Information provided by NCIC Clinical Trials Group

First Received: October 11, 2001 Last Updated: November 7, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	September 2008
Estimated Primary Completion Date:	No date given

Publications:

Canil CM, Moore MJ, Winquist E, Baetz T, Pollak M, Chi KN, Berry S, Ernst DS, Douglas L, Brundage M, Fisher B, McKenna A, Seymour L. Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group. J Clin Oncol. 2005 Jan 20;23(3):455-60.

Back to top of Main Content